Ryan A. Hollibaugh
Associate Director, Jnana Therapeutics
Ryan A. Hollibaugh is listed as Associate Director, Jnana Therapeutics. Ryan spoke at Drug Discovery Chemistry Europe 2026 in November 2026 (moderator, “Direct-to-Biology (D2B) Applications for Degrader and Small Molecule Lead Generation”). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Ryan. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Ryan is an associate director in the medicinal chemistry group at Jnana Therapeutics. In that role he leads multiple programs across both the immune and rare disease portfolios. Prior to joining Jnana in 2020 he received his PhD from the University of California Los Angeles and completed a postdoctoral fellowship with Jef De Brabander at UT Southwestern, where he focused on the total synthesis of the macrolide antibiotic Fidaxomicin.
Sessions at 1 conference
Drug Discovery Chemistry Europe 2026 11 November 2026 – 12 November 2026
- Direct-to-Biology (D2B) Applications for Degrader and Small Molecule Lead Generation Moderator · 10 November 2026
Spoke alongside
People who have shared a session with Ryan at events on B2DB.
- Sam M. Rowe Investigator · GSK 1 shared session